196 related articles for article (PubMed ID: 36733394)
1. Imidazolium salts as an alternative for anti-Leishmania drugs: Oxidative and immunomodulatory activities.
Baldissera FG; Fazolo T; da Silva MB; de Santana Filho PC; da Silva VD; Rivillo Perez DM; Klitzke JS; de Oliveira Soares EG; Rodrigues Júnior LC; Peres A; Dallegrave E; Navegantes-Lima KC; Monteiro MC; Schrekker HS; Torres Romão PR
Front Immunol; 2022; 13():1096312. PubMed ID: 36733394
[TBL] [Abstract][Full Text] [Related]
2. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
[TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
[TBL] [Abstract][Full Text] [Related]
4. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
7. Solidagenone acts on promastigotes of L. amazonensis by inducing apoptosis-like processes on intracellular amastigotes by IL-12p70/ROS/NO pathway activation.
Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Contato VM; Silva TF; de Matos RLN; Detoni MB; Rodrigues ACJ; Carloto AC; Lazarin DB; Arakawa NS; Costa IN; Conchon-Costa I; Miranda-Sapla MM; Wowk PF; Pavanelli WR
Phytomedicine; 2021 May; 85():153536. PubMed ID: 33765552
[TBL] [Abstract][Full Text] [Related]
8. Imidazolium salts as innovative agents against Leishmania amazonensis.
Martins RC; Dorneles GP; Teixeira VON; Antonello AM; Couto JL; Rodrigues Júnior LC; Monteiro MC; Peres A; Schrekker HS; Romão PRT
Int Immunopharmacol; 2018 Oct; 63():101-109. PubMed ID: 30077823
[TBL] [Abstract][Full Text] [Related]
9. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.
Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES
Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
11. Leishmania amazonensis and Leishmania chagasi: In vitro leishmanicide activity of Virola surinamensis (rol.) warb.
Veiga A; Albuquerque K; Corrêa ME; Brigido H; Silva E Silva J; Campos M; Silveira F; Santos L; Dolabela M
Exp Parasitol; 2017 Apr; 175():68-73. PubMed ID: 28174103
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action.
Morais LS; Dusi RG; Demarque DP; Silva RL; Albernaz LC; Báo SN; Merten C; Antinarelli LMR; Coimbra ES; Espindola LS
PLoS One; 2020; 15(11):e0241855. PubMed ID: 33156835
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
14. Microgramma vacciniifolia Frond Lectin: In Vitro Anti-leishmanial Activity and Immunomodulatory Effects Against Internalized Amastigote Forms of Leishmania amazonensis.
de Souza Aguiar LM; de Moraes Alves MM; Sobrinho Júnior EPC; Paiva PMG; de Amorim Carvalho FA; de Albuquerque LP; de Siqueira Patriota LL; Napoleão TH
Acta Parasitol; 2023 Dec; 68(4):869-879. PubMed ID: 37874484
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
[TBL] [Abstract][Full Text] [Related]
16. Dehydroabietic acid isolated from Pinus elliottii exerts in vitro antileishmanial action by pro-oxidant effect, inducing ROS production in promastigote and downregulating Nrf2/ferritin expression in amastigote forms of Leishmania amazonensis.
Gonçalves MD; Bortoleti BTS; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; Carvalho PGC; Tudisco ET; Urbano A; Ambrósio SR; Hirooka EY; Simão ANC; Costa IN; Pavanelli WR; Conchon-Costa I; Arakawa NS
Fitoterapia; 2018 Jul; 128():224-232. PubMed ID: 29802873
[TBL] [Abstract][Full Text] [Related]
17. Leishmanicidal effect of 1,3,4-thiadiazolium mesoionic salts on Leishmania amazonensis in vitro.
Dos Santos Rosa A; Frauches-Santos C; Santana RC; Gomes JSC; Lima K; Echevarria A; Saraiva E; Decote-Ricardo D; Atella G; Pinto-da-Silva LH
Parasitol Int; 2021 Aug; 83():102342. PubMed ID: 33831578
[TBL] [Abstract][Full Text] [Related]
18. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD
Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
